Qiagen (QGEN) Net Income towards Common Stockholders (2009 - 2025)
Qiagen's (QGEN) quarterly Net Income towards Common Stockholders came in at $522.0 million in Q4 2025, up 6.31% year-on-year from $491.0 million in Q4 2024, and up 301.41% quarter-over-quarter from $130.0 million in Q3 2025.
Qiagen (QGEN) Net Income towards Common Stockholders (2009 - 2025) Analysis & Trends
Qiagen has disclosed Net Income towards Common Stockholders across 17 years of filings, most recently posting $522.0 million for Q4 2025.
- Net Income towards Common Stockholders for Q4 2025 came in at $522.0 million, up 6.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $784.0 million (down 5.88% YoY), and the FY2025 annual result was $522.0 million, up 6.31% from the prior year.
- Net Income towards Common Stockholders came in at $522.0 million for Q4 2025 at Qiagen, up from $130.0 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $614.0 million in Q4 2021 to a low of $77.8 million in Q3 2023.
- The 5-year median for Net Income towards Common Stockholders is $123.0 million (2024), against an average of $203.7 million.
- Across the five-year window, Net Income towards Common Stockholders surged 423.81% in 2021 and tumbled 80.13% in 2022, its largest moves.
- Qiagen's Net Income towards Common Stockholders stood at $614.0 million in 2021, then sank by 80.13% to $122.0 million in 2022, then soared by 290.98% to $477.0 million in 2023, then climbed by 2.94% to $491.0 million in 2024, then increased by 6.31% to $522.0 million in 2025.
- The last three Net Income towards Common Stockholders figures came in at $522.0 million (Q4 2025), $130.0 million (Q3 2025), and $132.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 141.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Qiagen | 8.54 Bn | 7.44 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 522.00 Mn |
| Sep 30, 2025 | 130.04 Mn |
| Jun 30, 2025 | 132.00 Mn |
| Mar 31, 2025 | 121.00 Mn |
| Dec 31, 2024 | 491.00 Mn |
| Sep 30, 2024 | 98.06 Mn |
| Jun 30, 2024 | 123.00 Mn |
| Mar 31, 2024 | 104.00 Mn |
| Dec 31, 2023 | 477.00 Mn |
| Sep 30, 2023 | 77.82 Mn |
| Jun 30, 2023 | 80.79 Mn |
| Mar 31, 2023 | 85.04 Mn |
| Dec 31, 2022 | 122.00 Mn |
| Sep 30, 2022 | 82.39 Mn |
| Jun 30, 2022 | 118.00 Mn |
| Mar 31, 2022 | 184.00 Mn |
| Dec 31, 2021 | 614.00 Mn |
| Jun 30, 2021 | 155.00 Mn |
| Mar 31, 2021 | 154.00 Mn |
| Dec 31, 2020 | 212.69 Mn |